Best TWAS P=1.947021e-10 · Best GWAS P=3.548998e-09 conditioned to 0.3564941
# | Tissue | Gene | Modality | RNA phenotype | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | BLA | Ctsc | alternative polyA | ENSRNOT00000022342 | 0.07 | 0.00 | blup | 2518 | 0.01 | 5.1e-02 | 5.4 | -6.4 | 2.1e-10 | -0.73 | 0.44 | 0.22 | FALSE |
2 | BLA | Ctsc | alternative polyA | ENSRNOT00000097085 | 0.07 | 0.00 | blup | 2518 | 0.02 | 3.2e-02 | -4.6 | 6.3 | 3.5e-10 | 0.69 | 0.45 | 0.19 | FALSE |
3 | BLA | Ctsc | gene expression | ENSRNOG00000016496 | 0.12 | 0.10 | top1 | 1 | 0.10 | 5.0e-06 | 5.6 | 5.6 | 1.8e-08 | 0.94 | 0.23 | 0.35 | FALSE |
4 | BLA | Ctsc | mRNA stability | ENSRNOG00000016496 | 0.05 | 0.03 | top1 | 1 | 0.03 | 1.5e-02 | 5.6 | -5.6 | 1.9e-08 | -0.89 | 0.10 | 0.04 | FALSE |
5 | Brain | Grm5 | gene expression | ENSRNOG00000016429 | 0.16 | 0.10 | lasso | 6 | 0.15 | 5.3e-14 | 5.7 | -6.4 | 1.9e-10 | -0.85 | 0.30 | 0.70 | TRUE |
6 | Brain | Ctsc | isoform ratio | ENSRNOT00000022342 | 0.03 | 0.04 | top1 | 1 | 0.04 | 1.7e-04 | 5.9 | -5.9 | 3.5e-09 | -0.89 | 0.09 | 0.32 | FALSE |
7 | Eye | Ctsc | gene expression | ENSRNOG00000016496 | 0.29 | 0.15 | top1 | 1 | 0.15 | 2.9e-03 | 5.6 | 5.6 | 2.5e-08 | 0.92 | 0.14 | 0.06 | FALSE |
8 | IL | Ctsc | gene expression | ENSRNOG00000016496 | 0.30 | 0.16 | top1 | 1 | 0.16 | 1.0e-04 | 5.6 | 5.6 | 2.3e-08 | 0.92 | 0.13 | 0.07 | FALSE |
9 | PL | Grm5 | mRNA stability | ENSRNOG00000016429 | 0.04 | 0.03 | top1 | 1 | 0.03 | 1.3e-03 | 5.6 | 5.6 | 1.6e-08 | 0.92 | 0.09 | 0.06 | FALSE |
h2: Heritability estimate for the given transcriptomic model. PP3: Posterior probability of two distinct causal variants. PP4: Posterior probability of a single shared causal variant. joint: Whether the RNA phenotype is in the joint model.